International Patent Survey of Products and Processes Concerning Homeopathy

 

 Permissions and Reprints

Abstract

Background Homeopathy is a complementary medicine characterized by the use of diluted and potentized medicines. Innovations in this area are constantly being proposed in the relevant literature, such as scientific articles and patents. The objective of this study was to carry out a patent survey of homeopathic products and processes.

Methods A free and international patent database, Espacenet, was used. The search was carried out using the keyword homeop*, with two approaches: (1) no date restrictions for the search and (2) a date limit for the publication years 2008 to 2018. The patents from the limited period were organized as depositor countries, ownerships and groups, including homeopathic formulations, equipment, packaging, production procedures, and analytical methods.

Results Without date restriction, 601 patents were identified in the survey. Of these, 174 were related to homeopathy and published in the period 2008 to 2018. Technologies come mainly from the following countries: United States (55 patents), Russia (24), Germany (15), France (13), India (12), Ukraine (11), Brazil (6), and China (6). Among the ownerships, 69% of patent applications were by independent depositors, 23% by companies, 7.5% by universities, and 0.5% by company/university partnerships. New formulations represented 75.9% of technologies, whilst the others comprised 14.3% for equipment, 3.8% for drugs packaging, 3.8% for production procedures, and 2.2% for analytical methods.

Conclusions The present review helps visualize the homeopathy-related patents published in recent years, as well as the main countries and researchers investing in the field of homeopathy.

Highlights

• A patents review about homeopathy was performed.

• Inventors from the United States and Russia are the major applicants of homeopathy-based patents.

• Independent persons are the most common kind of applicants of homeopathy-based patents.

• The largest number of homeopathy-based patents involves new formulations.

Publication History

Received: 21 February 2020

Accepted: 14 May 2020

Article published online:
15 October 2020

© 2020. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 World Health Organization. Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organization; 2019
  Google Scholar
• 2 Merrell WC, Shalts E. Homeopathy. Med Clin North Am 2002; 86: 47-62
  CrossrefPubMedGoogle Scholar
• 3 Pustiglione M, Goldenstein E, Chencinski YM. Homeopathy: a brief description of this medical specialty. Rev Bras Homeopatia 2017; 80: 1-15
  PubMedGoogle Scholar
• 4 Teixeira MZ. Homeopathic vitalism along the history of medicine. Homeopat Bras 2002; 8: 109-123
  PubMedGoogle Scholar
• 5 Borneman JP, Field RI. Regulation of homeopathic drug products. Am J Health Syst Pharm 2006; 63: 86-91
  CrossrefPubMedGoogle Scholar
• 6 Khurana A, Sharma B, Bhatia M, Kaur H. International convention on World Homoeopathy Day: integrating homoeopathy in health care delivery. Indian J Res Homoeopathy 2016; 10: 199-205
  CrossrefPubMedGoogle Scholar
• 7 Dias CG, Almeida RB. Scientific production and technological production: transforming a scientific paper into patent applications. Einstein (Sao Paulo) 2013; 11: 1-10
  CrossrefPubMedGoogle Scholar
• 8 Narin F, Hamilton KS. Bibliometric performance measures. Scientometrics 1996; 36: 293-310
  CrossrefPubMedGoogle Scholar
• 9 Dziallas M, Blind K. Innovation indicators throughout the innovation process: an extensive literature analysis. Technovation 2019; 80-81: 3-29
  CrossrefPubMedGoogle Scholar
• 10 Rother ET. Systematic literature review X. Narrative review. Acta Paul Enferm 2007; 20: vii-viii
  CrossrefPubMedGoogle Scholar
• 11 Şenel E. Evolution of homeopathy: a scientometric analysis of global homeopathy literature between 1975 and 2017. Complement Ther Clin Pract 2019; 34: 165-173
  CrossrefPubMedGoogle Scholar
• 12 Kreutz T, de Matos SP, Koester LS. Recent patents on permeation enhancers for drug delivery through nails. Recent Pat Drug Deliv Formul 2019; 13: 203-218
  CrossrefPubMedGoogle Scholar
• 13 Zerva A, Simic S, Topakas E, Nikodinovic-Runic J. Applications of microbial laccases: patent review of the past decade (2009–2019). Catalysts 2019; 9: 1023
  CrossrefPubMedGoogle Scholar
• 14 Tonelli M, Cichero E. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present). Expert Opin Ther Pat 2020; 30: 137-145
  CrossrefPubMedGoogle Scholar
• 15 World Intellectual Property Indicators. 2017. Geneva: World Intellectual Property Organization; Accessed April 10, 2019 at: https://www.wipo.int/edocs/pubdocs/en/wipo_pub_941_2017.pdf
• 16 França E, Vasconcelos AG. Patentes de fitoterápicos no brasil: uma análise do andamento dos pedidos no período de 1995-2017. Cadernos de C&T 2018; 35: 329-359
  PubMedGoogle Scholar
• 17 Bloomberg. Accessed, April 10, 2019 at: https://www.bloomberg.com/research///stocks/private/person.asp?personId=331627940&privcapId=331328070&previousCapId=331328070&previousTitle=Cearna%20Aesthetics,%20Inc
• 18 Henry Spink Fundation. G-therapy. Accessed April 10, 2019 at: http://www.henryspink.org/g-therapy.htm
  Google Scholar
• 19 HomeoPet. Accessed April 10, 2019 at: https://www.homeopet.com/about-homeopet/
• 20 Boiron. Accessed April 10, 2019 at: https://www.boironusa.com/about/our-story
• 21 Martínez C. Patent families: when do different definitions really matter?. Scientometrics 2011; 86: 39-63
  CrossrefPubMedGoogle Scholar

• Supplementary Material